Mersana Therapeutics Presents Positive Data on Next-Gen Antibody-Drug Conjugate Technology

News   Apr 10, 2013

 
Mersana Therapeutics Presents Positive Data on Next-Gen Antibody-Drug Conjugate Technology
 
 
 
FURTHER INFORMATION
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE